Literature DB >> 24166573

Acute focal dystonia induced by a tricyclic antidepressant in a patient with Wilson disease: a case report.

T Litwin1, G Chabik, A Członkowska.   

Abstract

The authors present the case of a 19-year-old patient with Wilson disease (WD) who developed symptoms of acute focal dystonia of the left hand (a 'starfish' hand presentation) shortly after treatment with the tricyclic antidepressant clomipramine. The diagnosis of WD was made 8 months earlier based on abnormal copper metabolism parameters and was confirmed by genetic testing. Initially, the patient presented with akathisia, sialorrhea, oromandibular dystonia (occasionally grimacing) and slight dysarthria. The patient's symptoms diminished after treatment with d-penicillamine was initiated. No further deterioration was observed after copper-chelating therapy was started. The authors diagnosed acute focal dystonia induced by clomipramine. Botulinum toxin and intensive rehabilitation was initiated; complete regression of hand dystonia was observed. Based on the case, the authors suggest that care should be exercised with regard to starting medications that could potentially impact the extrapyramidal system in WD patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24166573     DOI: 10.5114/ninp.2013.38230

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  2 in total

Review 1.  Psychiatric manifestations in Wilson's disease: possibilities and difficulties for treatment.

Authors:  Tomasz Litwin; Petr Dusek; Tomasz Szafrański; Karolina Dzieżyc; Anna Członkowska; Janusz K Rybakowski
Journal:  Ther Adv Psychopharmacol       Date:  2018-03-06

2.  Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson's Disease: Six Cases and Literature Review.

Authors:  Harald Hefter; Sara Samadzadeh
Journal:  Toxins (Basel)       Date:  2021-03-29       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.